Interaction between integrin α9β1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis

被引:50
|
作者
Ross, EA [1 ]
Douglas, MR [1 ]
Wong, SH [1 ]
Ross, EJ [1 ]
Curnow, SJ [1 ]
Nash, GB [1 ]
Rainger, E [1 ]
Scheel-Toellner, D [1 ]
Lord, JM [1 ]
Salmon, M [1 ]
Buckley, CD [1 ]
机构
[1] Univ Birmingham, Inst Biomed Res, Div Immun & Infect, MRC Ctr Immune Regulat,Div Neurosci,Div Med Sci, Birmingham B15 2TT, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1182/blood-2005-07-2692
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
According to the prevailing paradigm, neutrophils are short-lived cells that undergo spontaneous apoptosis within 24 hours of their release from the bone marrow. However, neutrophil survival can be significantly prolonged within inflamed tissue by cytokines, inflammatory mediators, and hypoxia. During screening experiments aimed at identifying the effect of the adhesive microenvironment on neutrophil survival, we found that VCAM-1 (CD106) was able to delay both spontaneous and Fas-induced apoptosis. VCAM-1-mediated survival was as efficient as that induced by the cytokine IFN-beta and provided an additive, increased delay in apoptosis when given in combination with IFN-beta. VCAM-1 delivered its antiapoptotic effect through binding the integrin alpha(9)beta(1). The ago, signaling pathway shares significant features with the IFN-beta survival signaling pathway, requiring P13 kinase, NF-kappa B activation, as well as de novo protein synthesis, but the kinetics of NF-kappa B activation by VCAM-1 were slower and more sustained compared with IFN-beta. This study demonstrates a novel functional role for ago, in neutrophil biology and suggests that adhesive signaling pathways provide an important extrinsic checkpoint for the resolution of inflammatory responses in tissues.
引用
收藏
页码:1178 / 1183
页数:6
相关论文
共 50 条
  • [1] Domain 4 of vascular cell adhesion molecule-1 (VCAM-1) is a negative regulator of soluble VCAM-1 binding to integrin α4β1.
    Woodside, DG
    Kram, RM
    Billard, MJ
    Mitchell, JS
    McIntyre, BW
    Vanderslice, P
    Watowich, SS
    BLOOD, 2003, 102 (11) : 528A - 528A
  • [2] FULL LENGTH VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1)
    POLTE, T
    NEWMAN, W
    GOPAL, TV
    NUCLEIC ACIDS RESEARCH, 1990, 18 (19) : 5901 - 5901
  • [3] Microtubule is involved in the expression of vascular cell adhesion molecule-1 (VCAM-1).
    Asahina, A
    Tada, Y
    Nakamura, K
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 637 - 637
  • [4] CHARACTERIZATION OF THE PROMOTER FOR VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1)
    IADEMARCO, MF
    MCQUILLAN, JJ
    ROSEN, GD
    DEAN, DC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (23) : 16323 - 16329
  • [5] Thrombin induces endothelial intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)
    Fabrigoule, M
    Marin, V
    Boulay, V
    Bongrand, P
    Kaplanski, S
    Farnarier, C
    Kaplanski, G
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 269 - 269
  • [6] Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients
    Otsuki, M
    Hashimoto, K
    Morimoto, Y
    Kishimoto, T
    Kasayama, S
    DIABETES, 1997, 46 (12) : 2096 - 2101
  • [7] Expression and function of integrin α4β1 and vascular cell adhesion molecule-1 (VCAM-1) during sympathetic innervation of the heart
    Wingerd, KL
    Goodman, NL
    Leu, ST
    Clegg, DO
    DEVELOPMENTAL DYNAMICS, 2004, 231 (02) : 359 - 369
  • [8] The Role of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Predicting Complicated Appendicitis in Children
    Lin, Wen-Ya
    Lee, En-Pei
    Chen, Chun-Yu
    Guo, Bei-Cyuan
    Lin, Mao-Jen
    Wu, Han-Ping
    DIAGNOSTICS, 2024, 14 (12)
  • [9] Soluble vascular cell adhesion molecule-1 (VCAM-1) in the serum of patients with atopic dermatitis
    Chun, WH
    Lee, HJ
    Lee, KH
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) : 136 - 136
  • [10] Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1)
    Mayet, WJ
    Schwarting, A
    Orth, T
    Duchmann, R
    zumBuschenfelde, KHM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (02): : 259 - 267